RxDoctor Payments Data

Randall Eldridge, DPM

Podiatrist · Hickory, NCNPI 1497195341

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.7% of the total across 105 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 35 manufacturers reported payments, led by Organogenesis Inc. at 29.9% of the total.

$2,771in general payments, 2019–2025

Across 105 payments — averaging $26.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Organogenesis Inc.$828
  • Next Science LLC$241
  • Sanara Medtech Inc.$217
  • Musculoskeletal Transplant Foundation Inc.$193
  • Imbed Biosciences Inc.$163
  • Smith+Nephew$152
  • plus $978 from 29 others

What the payments were for

  • Food & beverage$2,73699%
  • Education$120%
  • Entertainment$231%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,771 in reported general payments places this provider in the 60th percentile of 109 podiatrist providers in North Carolina.

See all podiatrist providers in North Carolina

Medicare billing

Part B allowed, 2024
$189,527
Medicare patients
485
Services billed
2,466

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ciclopirox112$3,768
Clotrimazole-BetamethasoneClotrimazole/Betamethasone Dip116$2,830
Betamethasone Dipropionate24$1,136
Doxycycline Hyclate85$631
Mupirocin75$560
Terbinafine Hcl81$457
Ammonium Lactate21$371
Ketoconazole25$316
Prednisone159$177
SsdSilver Sulfadiazine14$144
Clindamycin Hcl16$120
Silver Sulfadiazine17$97
Meloxicam14$15

Paid to pharmacies, not to this prescriber.

Other podiatrist in Hickory

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →